Management of Diabetic Patient with Persistent Glucosuria and Ketonuria
This patient requires immediate evaluation for diabetic ketoacidosis (DKA) or starvation ketosis, with urgent measurement of venous blood gas, serum ketones (beta-hydroxybutyrate preferred), and electrolytes to determine if insulin therapy is needed. 1
Immediate Diagnostic Workup Required
The presence of chronic ketonuria alongside glucosuria demands urgent clarification of the patient's metabolic state. You must obtain:
- Venous blood gas (pH and bicarbonate) - venous pH is typically 0.03 units lower than arterial and is sufficient for monitoring 1
- Serum beta-hydroxybutyrate (preferred over urine ketones, which can be misleading during treatment) 1
- Serum electrolytes including anion gap calculation
- Complete metabolic panel (you already have BUN/creatinine, which are normal)
The traditional DKA triad includes hyperglycemia (>250 mg/dL), metabolic acidosis (pH <7.3, bicarbonate <18 mEq/L), and elevated ketones 2, 3. However, recent guidelines have de-emphasized hyperglycemia because euglycemic DKA is increasingly recognized, particularly with SGLT2 inhibitor use 2.
Critical Decision Points
If DKA is Confirmed (pH <7.3, bicarbonate <15-18 mEq/L, elevated ketones):
Initiate continuous intravenous regular insulin immediately along with aggressive fluid resuscitation 1. The A1c of 7.3% does NOT exclude acute DKA - this represents average glucose control over 3 months and tells you nothing about current metabolic decompensation.
- Start IV regular insulin at 0.1 units/kg/hour after initial bolus of 0.1 units/kg 1
- Provide isotonic saline initially, then add dextrose when glucose falls to 200-250 mg/dL 1, 4
- Critical pitfall: Continuing saline without glucose supplementation when plasma glucose normalizes leads to persistent ketoacidosis despite euglycemia 5. This case report demonstrates that inadequate glucose provision perpetuates ketone production even with normal blood sugar.
If Mild DKA (pH 7.0-7.3):
Subcutaneous or intramuscular regular insulin every hour is as effective as IV administration 1. Give priming dose of 0.4-0.6 units/kg (half IV, half SC/IM), then 0.1 unit/kg SC/IM hourly.
If Not in DKA (pH >7.3, normal bicarbonate):
This scenario suggests either:
- Starvation ketosis - inadequate carbohydrate intake causing physiologic ketone production
- SGLT2 inhibitor effect - if patient is on dapagliflozin, empagliflozin, or canagliflozin, these drugs cause persistent glucosuria and can trigger euglycemic DKA 6
Addressing the A1c of 7.3%
While the A1c is near goal, the presence of persistent ketonuria indicates inadequate insulin availability or utilization. After excluding acute DKA:
Intensify diabetes therapy according to the 2025 ADA guidelines 7:
- If not on metformin and eGFR >30 mL/min/1.73m² (which this patient has with normal creatinine), start metformin as first-line therapy
- Add basal insulin if catabolic features are present (weight loss, ketonuria, hypertriglyceridemia) - this patient has ketonuria, which is a red flag 7
- Consider GLP-1 receptor agonist or dual GIP/GLP-1 agonist for additional glucose control and weight management
Renal Function Considerations
The normal BUN (24 mg/dL) and creatinine (0.85 mg/dL) are reassuring, but you must:
- Check urine albumin-to-creatinine ratio (ACR) - not mentioned in your labs but essential for diabetic kidney disease screening 8, 9
- Calculate eGFR to guide medication dosing
- The presence of glucosuria with A1c 7.3% suggests the renal threshold for glucose is being exceeded, which typically occurs around 180 mg/dL - indicating significant postprandial hyperglycemia despite acceptable A1c
Common Pitfalls to Avoid
- Assuming A1c of 7.3% means adequate control - persistent ketonuria indicates metabolic decompensation regardless of A1c
- Stopping insulin too early during DKA treatment - continue until anion gap normalizes, not just until glucose normalizes 1, 4
- Failing to provide glucose during DKA treatment - add dextrose when glucose reaches 200-250 mg/dL to prevent persistent ketoacidosis 5
- Missing SGLT2 inhibitor-induced euglycemic DKA - can occur up to 11 days after stopping the medication 6
Monitoring Strategy
- Check venous pH and electrolytes every 2-4 hours during acute treatment 1
- Monitor for resolution: glucose <200 mg/dL, bicarbonate ≥18 mEq/L, pH >7.3 1
- Transition to subcutaneous insulin 1-2 hours before stopping IV insulin to prevent rebound hyperglycemia 1
The bottom line: Chronic ketonuria in a diabetic patient is never normal and demands immediate investigation for DKA, regardless of A1c level. The normal renal function is favorable, but does not exclude acute metabolic crisis.